Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Susan Burkeholder"'
Autor:
T Dao, Maren K. Levin, LS Muniz, LK Roberts, Joyce A. O'Shaughnessy, S Zurawski, R Timis, Xuan Wang, Virginia Pascual, G Zurawski, Anna Karolina Palucka, Jennifer L. Smith, Jacob Turner, Jacques Banchereau, Michael Grant, Susan Burkeholder, J Tarnowski, JP Finholt, Derek Blankenship
Publikováno v:
Cancer Research. 78:P3-05
BACKGROUND: Women with TNBC who do not achieve a pathologic complete response (pCR) with preoperative (preop) chemotherapy have a high risk of recurrence and death from BC. Immunotherapy is an attractive strategy as human BCs can be immunogenic, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::547ff0082f6b4e9b54002605d14c9541
https://doi.org/10.1158/1538-7445.sabcs17-p3-05-01
https://doi.org/10.1158/1538-7445.sabcs17-p3-05-01
Autor:
Jacques Banchereau, Karolina Palucka, Susan Burkeholder, Nicolas Taquet, Patricia Phipps, Jennifer P Finholt, Lee Roberts, Carson Harrod, Lynnette Walters
Publikováno v:
BioProcessing Journal. 7:28-33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3f7eccfb780c97d8b8c9e14fb878831
https://doi.org/10.12665/j71.taquet
https://doi.org/10.12665/j71.taquet
Autor:
Luz Stella Muniz, Jennifer L. Smith, Susan Burkeholder, Roxana Timis, Lee Roberts, Karolina Palucka, Joyce O'Shaughnessy, Melissa G Melton, Jessica Tarnowski, Maren K. Levin, Jennifer P Finholt
Publikováno v:
Journal of Clinical Oncology. 34:1086-1086
1086Background: Women with TNBC who do not achieve a pathologic complete response (pCR) with preoperative (preop) chemotherapy have a high risk of recurrence and death from breast cancer (BC). A hi...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c652d753cca9fbafdfd9e7c2117ee88a
https://doi.org/10.1200/jco.2016.34.15_suppl.1086
https://doi.org/10.1200/jco.2016.34.15_suppl.1086
Autor:
Susan Burkeholder, Bryan King, Lee Roberts, Amanda Cobb, Derek Blankenship, Holly Mead, Monica Montes, Jacques Banchereau, Rajaram Ranganathan, Jennifer P Finholt, A. Carson Harrod, A. Karolina Palucka, L Sloan, Yves Levy
Publikováno v:
Journal of immunological methods. 365(1-2)
In the search for a therapeutic HIV-1 vaccine, we describe herein the development of a monocyte-derived dendritic cell (DC) vaccine loaded with a mixture of HIV-1-antigen lipopeptides (ANRS HIV-LIPO-5 Vaccine). LIPO-5 is comprised of five HIV-1-antig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6dcf5e3864babab4e45889b75bd7e1f
https://pubmed.ncbi.nlm.nih.gov/21093448
https://pubmed.ncbi.nlm.nih.gov/21093448
Autor:
Susan Burkeholder, L Sloan, J Perry-Finholt, Holly Mead, Jacques Banchereau, Bryan King, Amanda Cobb, Monica Montes, Yves Levy, Rajaram Ranganathan, Anna Karolina Palucka, LK Roberts
Publikováno v:
Retrovirology, Vol 6, Iss Suppl 3, p P365 (2009)
Retrovirology
Retrovirology
Background Clinical trials have shown that dendritic cell (DC)-based vaccines can induce antigen-specific immune responses as well as clinical responses in patients with stage IV cancer. In this study, a monocyte-derived DC vaccine pulsed with HIV an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e376c57f2c8286400d7b3d627c504628
https://doaj.org/article/9dc0d60714ea42ebacac1ffe4be1388f
https://doaj.org/article/9dc0d60714ea42ebacac1ffe4be1388f
Autor:
Barry Cooper, Luis A. Piñeiro, Susan Burkeholder, Amy S. Lang, Marvin J. Stone, Guido A. Ordonez, Michael H. Park
Publikováno v:
Baylor University Medical Center Proceedings. 11:77-79
A 47-year-old woman (MC) with severe anemia and red cell aplasia was found to have a serum monoclonal immunoglobulin component (M-component) but no evidence of overt multiple myeloma. The patient w...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11a909f9c64e69b7f3083e80b7e8674a
https://doi.org/10.1080/08998280.1998.11930085
https://doi.org/10.1080/08998280.1998.11930085
Autor:
Madhav V. Dhodapkar, Joseph W. Fay, Susan Burkeholder, Sophie Paczesny, Dennis A. Johnston, A. Karolina Palucka, Jacques Banchereau, Hideki Ueno
Publikováno v:
Cancer immunology, immunotherapy : CII. 55(10)
Between March 1999 and May 2000, 18 HLA-A*0201(+) patients with metastatic melanoma were enrolled in a phase I trial using a dendritic cell (DC) vaccine generated by culturing CD34(+) hematopoietic progenitors. This vaccine includes Langerhans cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12aa07b19a51a6258bc3529955ec3873
https://pubmed.ncbi.nlm.nih.gov/16331519
https://pubmed.ncbi.nlm.nih.gov/16331519
Autor:
Knut M. Wittkowski, Joseph W. Fay, Jacques Banchereau, Susan Burkeholder, Ralph M. Steinman, Sophie Paczesny, A. Karolina Palucka, Madhav Dhodapkar
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 26(5)
Summary: There is evidence that dendritic cell (DC) vaccines induce tumor-specific immune responses that correlate with clinical responses. Little is known, however, about the kinetics of T-cell responses to antigens presented on DC vaccines. The aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6c8f17db1cabfcffcf96a6fd40a59e
https://pubmed.ncbi.nlm.nih.gov/12973032
https://pubmed.ncbi.nlm.nih.gov/12973032
Autor:
Jean Davoust, Karolina Palucka, Susan Burkeholder, Mahyar Nouri-Shirazi, Elizabeth T. Kraus, Jacques Banchereau, Diana Bell
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 165(7)
Due to their capacity to induce primary immune responses, dendritic cells (DC) are attractive vectors for immunotherapy of cancer. Yet the targeting of tumor Ags to DC remains a challenge. Here we show that immature human monocyte-derived DC capture
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::644c19629fb16527a48e93debd666241
https://pubmed.ncbi.nlm.nih.gov/11034385
https://pubmed.ncbi.nlm.nih.gov/11034385
Autor:
Bali Pulendran, Cecile Chalouni, Jacques Banchereau, Jean Davoust, Susan Burkeholder, Dania Caron, Elizabeth T. Kraus, Elisabeth Guinet, Charles R. Maliszewski, Joseph W. Fay, Karolina Palucka
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 165(1)
Dendritic cells (DCs) have a unique ability to stimulate naive T cells. Recent evidence suggests that distinct DC subsets direct different classes of immune responses in vitro and in vivo. In humans, the monocyte-derived CD11c+ DCs induce T cells to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9b96dd032fd4ee5632eb3fb2425fa5a
https://pubmed.ncbi.nlm.nih.gov/10861097
https://pubmed.ncbi.nlm.nih.gov/10861097